Evidence of associations between cytokine genes and subjective reports of sleep disturbance in oncology patients and their family caregivers

PLoS ONE

Volumn 7, Issue 7, 2012, Pages

  Miaskowski, Christine ^a   Cooper, Bruce A ^a   Dhruva, Anand ^b   Dunn, Laura B ^a   Langford, Dale J ^a   Cataldo, Janine K ^a   Baggott, Christina R ^a   Merriman, John D ^a   Dodd, Marylin ^a   Lee, Kathryn ^a   West, Claudia ^a   Paul, Steven M ^a   Aouizerat, Bradley E ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GAMMA INTERFERON; GAMMA INTERFERON RECEPTOR 1; I KAPPA B KINASE BETA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; MICRORNA; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; BRAIN CANCER; BREAST CANCER; CANCER DIAGNOSIS; CANCER PATIENT; CANCER RADIOTHERAPY; CAREGIVER BURDEN; CAUCASIAN; COMORBIDITY; CONTROLLED STUDY; CORRELATIONAL STUDY; DEPRESSION; DESCRIPTIVE RESEARCH; FATIGUE; FEMALE; GENE FREQUENCY; GENERAL SLEEP DISTURBANCE SCALE; GENETIC ASSOCIATION; GENOTYPE; HAPLOTYPE; HUMAN; KARNOFSKY PERFORMANCE STATUS; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; PHENOTYPE; PROSTATE CANCER; RATING SCALE; SINGLE NUCLEOTIDE POLYMORPHISM; SLEEP; SLEEP DISORDER;

CAREGIVERS; CYTOKINES; FEMALE; HUMANS; MALE; MIDDLE AGED; MODELS, STATISTICAL; NEOPLASMS; POLYMORPHISM, SINGLE NUCLEOTIDE; REGRESSION ANALYSIS; SELF REPORT; SLEEP DISORDERS;

EID: 84864241045     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0040560     Document Type: Article

References (78)

1. Berger AM, (2009) Update on the state of the science: sleep-wake disturbances in adult patients with cancer. Oncol Nurs Forum 36: E165-177.
2. Berger AM, Parker KP, Young-McCaughan S, Mallory GA, Barsevick AM, et al. (2005) Sleep wake disturbances in people with cancer and their caregivers: state of the science. Oncol Nurs Forum 32: E98-126.
3. Aouizerat BE, Dodd M, Lee K, West C, Paul SM, et al. (2009) Preliminary evidence of a genetic association between tumor necrosis factor alpha and the severity of sleep disturbance and morning fatigue. Biol Res Nurs 11: 27-41.
4. Fletcher BS, Paul SM, Dodd MJ, Schumacher K, West C, et al. (2008) Prevalence, severity, and impact of symptoms on female family caregivers of patients at the initiation of radiation therapy for prostate cancer. J Clin Oncol 26: 599-605.
5. Gibbins J, McCoubrie R, Kendrick AH, Senior-Smith G, Davies AN, et al. (2009) Sleep- wake disturbances in patients with advanced cancer and their family carers. J Pain Symptom Manage 38: 860-870.
6. Hearson B, McClement S, (2007) Sleep disturbance in family caregivers of patients with advanced cancer. Int J Palliat Nurs 13: 495-501.
7. Savard J, Villa J, Ivers H, Simard S, Morin CM, (2009) Prevalence, natural course, and risk factors of insomnia comorbid with cancer over a 2-month period. J Clin Oncol. 27: 5233-5239.
8. Miaskowski C, Lee K, Dunn L, Dodd M, Aouizerat BE, et al. (2011) Sleep-wake circadian activity rhythm parameters and fatigue in oncology patients before the initiation of radiation therapy. Cancer Nurs 34: 255-268.
9. Carney S, Koetters T, Cho M, West C, Paul SM, et al. (2011) Differences in sleep disturbance parameters between oncology outpatients and their family caregivers. J Clin Oncol 29: 1001-1006.
10. Davidson JR, MacLean AW, Brundage MD, Schulze K, (2002) Sleep disturbance in cancer patients. Soc Sci Med 54: 1309-1321.
11. Dhruva A, Lee K, Paul SM, West C, Dunn L, et al. (2012) Sleep-wake circadian activity rhythms and fatigue in family caregivers of oncology patients. Cancer Nurs 35: 70-81.
12. Foley KA, Sarsour K, Kalsekar A, Walsh JK, (2010) Subtypes of sleep disturbance: associations among symptoms, comorbidities, treatment, and medical costs. Behav Sleep Med 8: 90-104.
13. Hublin C, Partinen M, Koskenvuo M, Kaprio J, (2011) Heritability and mortality risk of insomnia-related symptoms: a genetic epidemiologic study in a population-based twin cohort. Sleep 34: 957-964.
14. Imeri L, Opp MR, (2009) How (and why) the immune system makes us sleep. Nat Rev Neurosci 10: 199-210.
15. Maurovich-Horvat E, Pollmacher TZ, Sonka K, (2008) The effects of sleep and sleep deprivation on metabolic, endocrine and immune parameters. Prague Med Rep 109: 275-285.
16. Pollmacher T, Haack M, Schuld A, Reichenberg A, Yirmiya R, (2002) Low levels of circulating inflammatory cytokines-do they affect human brain functions? Brain Behav Immun 16: 525-532.
17. Mullington JM, Simpson NS, Meier-Ewert HK, Haack M, (2010) Sleep loss and inflammation. Best Pract Res Clin Endocrinol Metab 24: 775-784.
18. Lange T, Dimitrov S, Born J, (2010) Effects of sleep and circadian rhythm on the human immune system. Ann N Y Acad Sci 1193: 48-59.
19. Cirelli C, (2009) The genetic and molecular regulation of sleep: from fruit flies to humans. Nat Rev Neurosci 10: 549-560.
20. Sehgal A, Mignot E, (2011) Genetics of sleep and sleep disorders. Cell 146: 194-207.
21. Larkin EK, Patel SR, Zhu X, Tracy RP, Jenny NS, et al. (2010) Study of the relationship between the interleukin-6 gene and obstructive sleep apnea. Clin Transl Sci 3: 337-339.
22. Miaskowski C, Dodd M, Lee K, West C, Paul SM, et al. (2010) Preliminary evidence of an association between a functional interleukin-6 polymorphism and fatigue and sleep disturbance in oncology patients and their family caregivers. J Pain Symptom Manage 40: 531-544.
23. Dunn LB, Aouizerat BE, Cooper BA, Dodd M, Lee K, et al. (2012) Trajectories of anxiety in oncology patients and family caregivers during and after radiation therapy. Eur J Oncol Nurs 16: 1-9.
24. Buysse DJ, Reynolds CF, 3rd, Monk TH, Berman SR, Kupfer DJ (1989) The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res 28: 193-213.
25. Beck SL, Schwartz AL, Towsley G, Dudley W, Barsevick A, (2004) Psychometric evaluation of the Pittsburgh Sleep Quality Index in cancer patients. J Pain Symptom Manage 27: 140-148.
26. Carpenter JS, Andrykowski MA, (1998) Psychometric evaluation of the Pittsburgh Sleep Quality Index. J Psychosom Res 45: 5-13.
27. Garrett K, Dhruva A, Koetters T, West C, Paul SM, et al. (2011) Differences in sleep disturbance and fatigue between patients with breast and prostate cancer at the initiation of radiation therapy. J Pain Symptom Manage 42: 239-250.
28. Lee KA, (1992) Self-reported sleep disturbances in employed women. Sleep15: 493-498.
29. Lee KA, DeJoseph JF, (1992) Sleep disturbances, vitality, and fatigue among a select group of employed childbearing women. Birth 19: 208-213.
30. Miaskowski C, Lee KA, (1999) Pain, fatigue, and sleep disturbances in oncology outpatients receiving radiation therapy for bone metastasis: a pilot study. J Pain Symptom Manage 17: 320-332.
31. Lee KA, Hicks G, Nino-Murcia G, (1991) Validity and reliability of a scale to assess fatigue. Psychiatry Res 36: 291-298.
32. Gay CL, Lee KA, Lee SY, (2004) Sleep patterns and fatigue in new mothers and fathers. Biol Res Nurs 5: 311-318.
33. Lee KA, Portillo CJ, Miramontes H, (1999) The fatigue experience for women with human immunodeficiency virus. J Obstet Gynecol Neonatal Nurs 28: 193-200.
34. Miaskowski C, Paul SM, Cooper BA, Lee K, Dodd M, et al. (2008) Trajectories of fatigue in men with prostate cancer before, during, and after radiation therapy. J Pain Symptom Manage 35: 632-643.
35. Miaskowski C, Cooper BA, Paul SM, Dodd M, Lee K, et al. (2006) Subgroups of patients with cancer with different symptom experiences and quality-of-life outcomes: a cluster analysis. Oncol Nurs Forum 33: E79-89.
36. Radloff LS, (1977) The CES-D Scale: A self-report depression scale for research in the general population. Applied Psychological Measurement 1: 385-401.
37. Sheehan TJ, Fifield J, Reisine S, Tennen H, (1995) The measurement structure of the Center for Epidemiologic Studies Depression Scale. J Pers Assess 64: 507-521.
38. Carpenter JS, Andrykowski MA, Wilson J, Hall LA, Rayens MK, et al. (1998) Psychometrics for two short forms of the Center for Epidemiologic Studies-Depression Scale. Issues Ment Health Nurs 19: 481-494.
39. Kennedy BL, Schwab JJ, Morris RL, Beldia G, (2001) Assessment of state and trait anxiety in subjects with anxiety and depressive disorders. Psychiatr Q 72: 263-276.
40. Bieling PJ, Antony MM, Swinson RP, (1998) The State-Trait Anxiety Inventory, Trait version: structure and content re-examined. Behav Res Ther 36: 777-788.
41. Spielberger CG, Gorsuch RL, Suchene R, Vagg PR, Jacobs GA. (1983) Manual for the State- Anxiety (Form Y): Self Evaluation Questionnaire. Palo Alto, CA: Consulting Psychologists Press.
42. Cimprich B, Visovatti M, Ronis DL, (2011) The Attentional Function Index-a self-report cognitive measure. Psychooncology 20: 194-202.
43. Cimprich B, (1992) Attentional fatigue following breast cancer surgery. (1992) Res Nurs Health 15: 199-207.
44. Cimprich B, So H, Ronis DL, Trask C, (2005) Pre-treatment factors related to cognitive functioning in women newly diagnosed with breast cancer. Psychooncology 14: 70-78.
45. Daut RL, Cleeland CS, Flanery RC, (1983) Development of the Wisconsin Brief Pain Questionnaire to assess pain in cancer and other diseases. Pain 17: 197-210.
46. Berger AM, Wielgus KK, Young-McCaughan S, Fischer P, Farr L, et al. (2008) Methodological challenges when using actigraphy in research. J Pain Symptom Manage 36: 191-199.
47. Morgenthaler T, Alessi C, Friedman L, Owens J, Kapur V, et al. (2007) Practice parameters for the use of actigraphy in the assessment of sleep and sleep disorders: an update for 2007. Sleep 30: 519-529.
48. Ancoli-Israel S, Cole R, Alessi C, Chambers M, Moorcroft W, et al. (2003) The role of actigraphy in the study of sleep and circadian rhythms. Sleep 26: 342-392.
49. Buysse DJ, Ancoli-Israel S, Edinger JD, Lichstein KL, Morin CM, (2006) Recommendations for a standard research assessment of insomnia. Sleep 29: 1155-1173.
50. Berger AM, Farr LA, Kuhn BR, Fischer P, Agrawal S, (2007) Values of sleep/wake, activity/rest, circadian rhythms, and fatigue prior to adjuvant breast cancer chemotherapy. J Pain Symptom Manage 33: 398-409.
51. Berger AM, Wielgus K, Hertzog M, Fischer P, Farr L, (2009) Patterns of circadian activity rhythms and their relationships with fatigue and anxiety/depression in women treated with breast cancer adjuvant chemotherapy. Support Care Cancer.
52. SPSS. IBM SPSS for Windows (Version 19) (2010) Chicago, Illinois: SPSS, Inc.
53. Muthen LK, Muthen BO (1998-2010) Mplus User's Guide (6th ed.). Los Angeles, CA: Muthen & Muthen.
54. Muthen BO, Kaplan DW, (2004) Latent variable analysis: Growth mixture modeling and related techniques for longitudinal data. In: Kaplan D, editors. pp. 345-368 editor. The Sage Handbook of Quantitative Methodology for the Social Sciences. Newbury Park, CA: Sage Publications. p.
55. Jung T, Wickrama KAS, (2008) An introduction to latent class growth analysis and growth mixture modeling. Social and Personality Psychology Compass. 2: 302-317.
56. Nylund KL, Asparouhov T, Muthen BO, (2007) Deciding on the number of classes in latent class analysis and growth mixture modeling: A Monte Carlo simulation study. Struct Equ Modeling 14: 535-569.
57. Tofighi D, Enders CK, (2008) Identifying the correct number of classes in growth mixture models. Charlotte, NC: Information Age Publishing.
58. Celeux G, Soromenho G, (1996) An entropy criterion for assessing the number of clusters in a mixture model. Journal of Classification 13: 195-212.
59. Muthen BO, (2002) Beyond SEM: General latent variable modeling. Behaviormetrika 29: 81-117.
60. Schafer JL, Graham JW, (2002) Missing data: our view of the state of the art. Psychol Methods 7: 147-77.
61. Seruga B, Zhang H, Bernstein LJ, Tannock IF, (2008) Cytokines and their relationship to the symptoms and outcome of cancer. Nat Rev Cancer 8: 887-899.
62. Conde L, Vaquerizas JM, Dopazo H, Arbiza L, Reumers J, et al. (2006) PupaSuite: finding functional single nucleotide polymorphisms for large-scale genotyping purposes. Nucleic Acids Res 34: W621-625.
63. Gabriel SB, Schaffner SF, Nguyen H, Moore JM, Roy J, et al. (2002) The structure of haplotype blocks in the human genome. Science 296: 2225-2229.
64. Stephens M, Smith NJ, Donnelly P, (2001) A new statistical method for haplotype reconstruction from population data. Am J Hum Genet 68: 978-989.
65. Rothman KJ, (1990) No adjustments are needed for multiple comparisons. Epidemiology. 1: 43-46.
66. Hoggart CJ, Parra EJ, Shriver MD, Bonilla C, Kittles RA, et al. (2003) Control of confounding of genetic associations in stratified populations. Am J Hum Genet 72: 1492-1504.
67. Halder I, Shriver M, Thomas M, Fernandez JR, Frudakis T, (2008) A panel of ancestry informative markers for estimating individual biogeographical ancestry and admixture from four continents: utility and applications. Hum Mutat 29: 648-658.
68. Tian C, Gregersen PK, Seldin MF, (2008) Accounting for ancestry: population substructure and genome-wide association studies. Hum Mol Genet 17: R143-150.
69. Price AL, Patterson NJ, Plenge RM, Weinblatt ME, Shadick NA, et al. (2006) Principal components analysis corrects for stratification in genome-wide association studies. Nat Genet 38: 904-909.
70. Osoba D, (1999) Interpreting the meaningfulness of changes in health-related quality of life scores: lessons from studies in adults. Int J Cancer pp. 132-137.
71. Osoba D, Rodrigues G, Myles J, Zee B, Pater J, (1998) Interpreting the significance of changes in health-related quality-of-life scores. J Clin Oncol 16: 139-144.
72. Fortner BV, Stepanski EJ, Wang SC, Kasprowicz S, Durrence HH, (2002) Sleep and quality of life in breast cancer patients. J Pain Symptom Manage 24: 471-480.
73. Chen ML, Yu CT, Yang CH, (2008) Sleep disturbances and quality of life in lung cancer patients undergoing chemotherapy. Lung Cancer 62: 391-400.
74. Pud D, Ben Ami S, Cooper BA, Aouizerat BE, Cohen D, et al. (2008) The symptom experience of oncology outpatients has a different impact on quality-of-life outcomes. J Pain Symptom Manage 35: 162-170.
75. Cho MH, Dodd MJ, Lee KA, Padilla G, Slaughter R, (2006) Self-reported sleep quality in family caregivers of gastric cancer patients who are receiving chemotherapy in Korea. J Cancer Educ 21: S37-41.
76. Schmitz ML, Mattioli I, Buss H, Kracht M, (2004) NF-kappaB: a multifaceted transcription factor regulated at several levels. Chembiochem 5: 1348-1358.
77. Libermann TA, Baltimore D, (1990) Activation of interleukin-6 gene expression through the NF-kappa B transcription factor. Mol Cell Biol 10: 2327-2334.
78. Heffner KL, France CR, Trost Z, Ng HM, Pigeon WR, (2011) Chronic low back pain, sleep disturbance, and interleukin-6. Clin J Pain 27: 35-41.